Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey

被引:0
|
作者
Vasile, E. [1 ]
Di Girolamo, S. [2 ]
Cereda, S. [3 ]
Lonardi, S. [4 ]
Leone, F. [5 ]
Russano, M. [6 ]
Silvestris, N. [7 ]
Vivaldi, C. [1 ]
Fornaro, L. [8 ]
Brandi, G. [2 ]
机构
[1] Azienda Osped Univ Pisana, Pisa, Italy
[2] Univ Bologna, St Orsola Malpighi Hosp, Bologna, Italy
[3] Ist Sci San Raffaele, I-20132 Milan, Italy
[4] Ist Oncol Veneto, Padua, Italy
[5] Univ Turin, Inst Canc Res & Treatment IRCC Candiolo, Turin, Italy
[6] Campus Biomed Univ, Rome, Italy
[7] IRCCS Osped Oncol, Inst Canc Res & Treatment, Bari, Italy
[8] Azienda USL 2, Lucca, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2585
引用
收藏
页码:S614 / S614
页数:1
相关论文
共 50 条
  • [1] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Second-line FOLFOX chemotherapy for advanced biliary tract cancer
    Brandi, Giovanni
    Frega, Giorgio
    Rizzo, Alessandro
    [J]. LANCET ONCOLOGY, 2021, 22 (07): : E285 - E285
  • [3] Benefit of second-line chemotherapy for advanced biliary tract cancer.
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Bezan, Angelika
    Rossmann, Christopher
    Szkandera, Joanna
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES
    Brungs, Daniel
    Aghmesheh, Morteza
    Sjoquist, Katrin
    Goldstein, David
    [J]. Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 168 - 168
  • [5] Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
    Fiteni, Frederic
    Jary, Marine
    Monnien, Franck
    Nguyen, Thierry
    Beohou, Eric
    Demarchi, Martin
    Dobi, Erion
    Fein, Francine
    Cleau, Denis
    Fratte, Serge
    Nerich, Virginie
    Bonnetain, Franck
    Pivot, Xavier
    Borg, Christophe
    Kim, Stefano
    [J]. BMC GASTROENTEROLOGY, 2014, 14
  • [6] Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
    Frédéric Fiteni
    Marine Jary
    Franck Monnien
    Thierry Nguyen
    Eric Beohou
    Martin Demarchi
    Erion Dobi
    Francine Fein
    Denis Cleau
    Serge Fratté
    Virginie Nerich
    Franck Bonnetain
    Xavier Pivot
    Christophe Borg
    Stefano Kim
    [J]. BMC Gastroenterology, 14
  • [7] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Second-line chemotherapy in advanced biliary tract cancer: Who may benefit?
    Salati, Massimiliano
    Caputo, Francesco
    Marcheselli, Luigi
    Rimini, Margherita
    Spallanzani, Andrea
    Gelsomino, Fabio
    Andrikou, Kalliopi
    Zironi, Sandra
    Di Emidio, Katia
    Clo', Vera
    Luppi, Gabriele
    Cascinu, Stefano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [9] Capecitabine and cisplatin as a second-line chemotherapy for patients with advanced biliary tract cancer
    Shin, Kabsoo
    Lee, In Seok
    Hong, Tae Ho
    Kim, Joori
    Lee, Myung Ah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [10] Outcome of second-line chemotherapy for biliary tract cancer
    Bridgewater, John
    Palmer, Daniel
    Cunningham, David
    Iveson, Tim
    Gillmore, Roopinder
    Waters, Justin
    Harrison, Mark
    Wasan, Harpreet
    Corrie, Pippa
    Valle, Juan
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1511 - 1511